Twist Bioscience Reports Fiscal Fourth Quarter and Full Year Fiscal 2022 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/18/2026
- Wall St set for tepid open as oil prices fall, Treasury yields rise
- Oil prices edge lower on easing fears over Saudi supply disruption
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
Twist Bioscience Corporation (TWST) Tops Q4 EPS by 36c, Offers Guidance
November 18, 2022 7:33 AM ESTTwist Bioscience Corporation (NASDAQ: TWST) reported Q4 EPS of ($0.91), $0.36 better than the analyst estimate of ($1.27). Revenue for the quarter came in at $57.3 million versus the consensus estimate of $56.78 million.
GUIDANCE:
Twist Bioscience Corporation sees Q1 2023 revenue of $54 million, versus the... More
